Temasek’s 65 Equity Makes Europe Foray With Swiss Pharma Merger
Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s ...
The Woodlands-based company strikes obesity-drug license deal worth up to $1B
Lexicon Pharmaceuticals Inc. said March 28 it will exclusively license its drug candidate LX9851 to Danish pharmaceutical ...
Vertex Pharmaceuticals pursuing research-stage T1Dd programs
Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...
Philippine News Agency2d
PEZA to host PH's first US-FDA certified pharma manufacturer
The Philippine Economic Zone Authority (PEZA) said Friday that a new ecozone in Tarlac will host the country’s first ...
BioWorld3d
Suzhou Zion Pharma Technology presents new KRAS inhibitors
Suzhou Zion Pharma Technology Co. Ltd. has identified GTPase KRAS G12D or G13D mutant and/or KRAS inhibitors reported to be useful for the treatment of cancer.
TipRanks on MSN5d
Abbisko Therapeutics Receives IND Clearance for Innovative Achondroplasia Treatment
Abbisko Cayman Limited ( ($HK:2256) ) has shared an announcement. Abbisko Therapeutics announced that the Center for Drug Evaluation of the China ...